Search Within

Sloan Kettering Institute Faculty

Formats
  1. Journal Article (10886)
  2. Meeting Abstract (3786)
  3. Book Section (323)
  4. Review (252)
  5. Conference Paper (207)
  6. Editorial (149)
  7. Research Letter (43)
  8. Book Whole (34)
  9. Miscellaneous (21)
  10. Correspondence (17)
  11. Guidelines (6)
Groups
  1. GSK Faculty (11541)
  2. Molecular Pharmacology and Chemistry Program Faculty (7510)
  3. Department of Medicine (4941)
  4. Center for Molecular Imaging and Biotechnology (CMIB) (4526)
  5. Sloan Kettering Institute Postdocs (3537)
  6. Center for Hematologic Malignancies (3363)

More Groups

People
  1. Murray Brennan (1059)
  2. Steven Larson (959)
  3. Richard O'Reilly (748)
  4. Peter Scardino (671)
  5. Marcel Van Den Brink (618)
  6. Michel Sadelain (586)

More People

Years
  1. 2025 (178)
  2. 2024 (327)
  3. 2023 (367)
  4. 2022 (431)
  5. 2021 (455)
  6. 2020 (475)

More Years

Publications
  1. Blood (1057)
  2. Cancer Research (580)
  3. Journal of Clinical Oncology (392)
  4. Journal of Nuclear Medicine (387)
  5. Journal of Biological Chemistry (370)
  6. Proceedings of the National Academy of Sciences of the United States of America (369)

More Publications

Publishers
  1. Nature Publishing Group (1508)
  2. Elsevier Inc. (1399)
  3. American Association for Cancer Research (1174)
  4. American Society of Hematology (1075)
  5. Cell Press (1025)
  6. Wiley Blackwell (611)

More Publishers

Results (15724)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Structures of fission yeast inositol pyrophosphate kinase Asp1 in ligand-free, substrate-bound, and product-bound states
    Journal Article

    Benjamin, B.; Goldgur, Y.; Jork, N.; Jessen, H. J.; Schwer, B.; Shuman, S.
    mBio (2022)

    Fulltext@MSK | Save
  • Maintenance of lineage identity: Lessons from a B cell
    Review

    Belcheva, K. T.; Chaudhuri, J.
    Journal of Immunology (2022)

    Fulltext@MSK | Save
  • Clinical trial participation among older adult Medicare fee-for-service beneficiaries with cancer
    Journal Article

    Green, A. K.; Tabatabai, S. M.; Aghajanian, C.; Landgren, O.; Riely, G. J.; Sabbatini, P.; Bach, P. B.; Begg, C. B.; Lipitz-Snyderman, A.; Mailankody, S.
    JAMA Oncology (2022)

    Fulltext@MSK | Save
  • Increased tumor glycolysis is associated with decreased immune infiltration across human solid tumors
    Journal Article

    Cohen, I. J.; Pareja, F.; Socci, N. D.; Shen, R.; Doane, A. S.; Schwartz, J.; Khanin, R.; Morris, E. A.; Sutton, E. J.; Blasberg, R. G.
    Frontiers in Immunology (2022)

    Fulltext@MSK | Save
  • Evolution and regulation of microbial secondary metabolism
    Journal Article

    Santamaria, G.; Liao, C.; Lindberg, C.; Chen, Y.; Wang, Z.; Rhee, K.; Pinto, F. R.; Yan, J.; Xavier, J. B.
    eLife (2022)

    Fulltext@MSK | Save
  • An immunocompetent rectal cancer model to study radiation therapy
    Journal Article

    Kim, J. K.; Wu, C.; Del Latto, M.; Gao, Y.; Choi, S. H.; Kierstead, M.; Gabriel SauveĢ, C. E.; Firat, C.; Perez, A. C.; Sillanpaa, J.; more...
    Cell Reports Methods (2022)

    Fulltext@MSK | Save
  • Phase 1 study of intraventricular (131)I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies
    Meeting Abstract

    Modak, S.; Pandit Taskar, N.; Kushner, B.; Zanzonico, P.; Humm, J.; Donzelli, M.; Lewis, J.; Lyashchenko, S.; Chu, B.; Larson, S.; more...
    Pediatric Blood and Cancer (2022)

    Fulltext@MSK | Save
  • A phase 1b study to evaluate safety, tolerability, pharmacokinetics, and efficacy of SER-155 in adults undergoing hematopoietic stem cell transplantation to reduce the risk of infection and graft versus host disease (NCT04995653)
    Meeting Abstract

    Ponce, D. M.; Lombardo, M. J.; Ford, C. B.; Peled, J. U.; Van Den Brink, M. R. M.; Tejura, B.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Clinicopathologic characterization of ERK2 E322K mutation in solid tumors: Implications for treatment and drug development
    Meeting Abstract

    Liu, D.; Murciano-Goroff, Y. R.; Jee, J.; Arcila, M. E.; Buonocore, D. J.; Gao, J.; Chakravarty, D.; Schram, A. M.; Callahan, M. K.; Friedman, C. F.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • STARLITE 2: Phase 2 study of nivolumab plus (177)Lutetium-labeled anti-carbonic anhydrase IX (CAIX) monoclonal antibody girentuximab ((177)Lu-girentuximab) in patients (pts) with advanced clear cell renal cell carcinoma (ccRCC)
    Meeting Abstract

    Feldman, D. R.; Motzer, R. J.; Knezevic, A.; Lee, C. H.; Voss, M. H.; Lyashchenko, S. K.; Park, H.; Larson, S. M.; Pandit-Taskar, N.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save